Correlation Between Opus Genetics, and BrightSpring Health

Can any of the company-specific risk be diversified away by investing in both Opus Genetics, and BrightSpring Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opus Genetics, and BrightSpring Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Opus Genetics, and BrightSpring Health Services,, you can compare the effects of market volatilities on Opus Genetics, and BrightSpring Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opus Genetics, with a short position of BrightSpring Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opus Genetics, and BrightSpring Health.

Diversification Opportunities for Opus Genetics, and BrightSpring Health

0.05

Correlation Coefficient

Opus Genetics,  BrightSpring Health

Significant diversification

The 3 months correlation between Opus and BrightSpring is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Opus Genetics, and BrightSpring Health Services, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BrightSpring Health and Opus Genetics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opus Genetics, are associated (or correlated) with BrightSpring Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BrightSpring Health has no effect on the direction of Opus Genetics, i.e., Opus Genetics, and BrightSpring Health go up and down completely randomly.

Pair Corralation between Opus Genetics, and BrightSpring Health

Considering the 90-day investment horizon Opus Genetics, is expected to under-perform the BrightSpring Health. In addition to that, Opus Genetics, is 1.84 times more volatile than BrightSpring Health Services,. It trades about -0.01 of its total potential returns per unit of risk. BrightSpring Health Services, is currently generating about 0.05 per unit of volatility. If you would invest  6,195  in BrightSpring Health Services, on December 30, 2024 and sell it today you would earn a total of  358.00  from holding BrightSpring Health Services, or generate 5.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Opus Genetics,  vs.  BrightSpring Health Services,

Opus Genetics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Opus Genetics, is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

BrightSpring Health

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in BrightSpring Health Services, are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating technical and fundamental indicators, BrightSpring Health may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Opus Genetics, and BrightSpring Health

The main advantage of trading using opposite Opus Genetics, and BrightSpring Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opus Genetics, position performs unexpectedly, BrightSpring Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BrightSpring Health will offset losses from the drop in BrightSpring Health's long position.

The idea behind Opus Genetics, and BrightSpring Health Services, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.